American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study

    NEXT STORY
    Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research
    PREV STORY
    Histology and Cytology Market To Reach USD 30,543.4 Million By 2026 | Reports And Data
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Skyline Medical Announces Corporate Name Change to Precision Therapeutics

    MINNEAPOLIS, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc (NASDAQ:SKLN) (“Skyline” or the ...

    author_avatar
    NASDAQ Market News

    Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone

    author_avatar
    NASDAQ Market News

    Genesis HealthCare Reports First Quarter 2018 Results

    KENNETT SQUARE, Pa., May 10, 2018 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or ...

    author_avatar
    NASDAQ Market News